Association Between Device-Detected Sleep-Disordered Breathing and Implantable Defibrillator Therapy in Patients With Heart Failure.


Journal

JACC. Clinical electrophysiology
ISSN: 2405-5018
Titre abrégé: JACC Clin Electrophysiol
Pays: United States
ID NLM: 101656995

Informations de publication

Date de publication:
10 2022
Historique:
received: 01 04 2022
revised: 05 07 2022
accepted: 10 07 2022
entrez: 20 10 2022
pubmed: 21 10 2022
medline: 25 10 2022
Statut: ppublish

Résumé

Sleep-disordered breathing is highly prevalent in heart failure (HF) and has been suggested as a risk factor for malignant ventricular arrhythmias. The Respiratory Disturbance Index (RDI) computed by an implantable cardioverter-defibrillator (ICD) algorithm accurately identifies severe sleep apnea. In the present analysis, the authors evaluated the association between ICD-detected sleep apnea and the incidence of appropriate ICD therapies in patients with HF. We enrolled 411 HF patients who had received an ICD endowed with an algorithm that calculates the RDI each night. In this analysis, the weekly mean RDI value was considered. The endpoint was the first appropriate ICD shock. The median follow-up was 26 months (25th to 75th percentile: 16-35 months). During follow-up, 1 or more ICD shocks were documented in 58 (14%) patients. Patients with shocks were younger (age 66 ± 13 years vs 70 ± 10 years; P = 0.038), and had more frequently undergone implantation for secondary prevention (21% vs 10%; P = 0.026). The maximum RDI value calculated during the entire follow-up period did not differ between patients with and without shocks (55 ± 15 episodes/h vs 54 ± 14 episodes/h; P = 0.539). However, the ICD-detected RDI showed considerable variability during follow-up. The overall median of the weekly RDI was 33 episodes/h (25th to 75th percentile: 24-45 episodes/h). A time-dependent Cox regression model revealed that a continuously measured weekly mean RDI of ≥45 episodes/h was independently associated with shock occurrence (HR: 4.63; 95% CI: 2.54-8.43; P < 0.001), after correction for baseline confounders (age, secondary prevention). In HF patients, appropriate ICD shocks were more likely to be delivered during periods when patients exhibited more sleep-disordered breathing. (Arrhythmias Detection in a Real World Population [RHYTHM DETECT]; NCT02275637).

Sections du résumé

BACKGROUND
Sleep-disordered breathing is highly prevalent in heart failure (HF) and has been suggested as a risk factor for malignant ventricular arrhythmias. The Respiratory Disturbance Index (RDI) computed by an implantable cardioverter-defibrillator (ICD) algorithm accurately identifies severe sleep apnea.
OBJECTIVES
In the present analysis, the authors evaluated the association between ICD-detected sleep apnea and the incidence of appropriate ICD therapies in patients with HF.
METHODS
We enrolled 411 HF patients who had received an ICD endowed with an algorithm that calculates the RDI each night. In this analysis, the weekly mean RDI value was considered. The endpoint was the first appropriate ICD shock.
RESULTS
The median follow-up was 26 months (25th to 75th percentile: 16-35 months). During follow-up, 1 or more ICD shocks were documented in 58 (14%) patients. Patients with shocks were younger (age 66 ± 13 years vs 70 ± 10 years; P = 0.038), and had more frequently undergone implantation for secondary prevention (21% vs 10%; P = 0.026). The maximum RDI value calculated during the entire follow-up period did not differ between patients with and without shocks (55 ± 15 episodes/h vs 54 ± 14 episodes/h; P = 0.539). However, the ICD-detected RDI showed considerable variability during follow-up. The overall median of the weekly RDI was 33 episodes/h (25th to 75th percentile: 24-45 episodes/h). A time-dependent Cox regression model revealed that a continuously measured weekly mean RDI of ≥45 episodes/h was independently associated with shock occurrence (HR: 4.63; 95% CI: 2.54-8.43; P < 0.001), after correction for baseline confounders (age, secondary prevention).
CONCLUSIONS
In HF patients, appropriate ICD shocks were more likely to be delivered during periods when patients exhibited more sleep-disordered breathing. (Arrhythmias Detection in a Real World Population [RHYTHM DETECT]; NCT02275637).

Identifiants

pubmed: 36266001
pii: S2405-500X(22)00647-8
doi: 10.1016/j.jacep.2022.07.017
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02275637']

Types de publication

Clinical Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1249-1256

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures Drs Campari and Valsecchi are employees of Boston Scientific, Inc. Dr Boriani has received small speaker fees from Boston, Biotronik, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Andrea Mazza (A)

Cardiology Division, Santa Maria della Stella Hospital, Orvieto, Italy.

Maria Grazia Bendini (MG)

Cardiology Division, Santa Maria della Stella Hospital, Orvieto, Italy.

Valter Bianchi (V)

Unità Operativa di Elettrofisiologia, Studio e Terapia deli Aritmie," Monaldi Hospital, Naples, Italy.

Cristina Esposito (C)

Ospedali Riuniti San Giovanni di Dio Ruggi d'Aragona, Salerno, Italy.

Leonardo Calò (L)

Policlinico Casilino, Rome, Italy.

Chiara Andreoli (C)

San Giovanni Battista Hospital, Foligno, Italy.

Vincenzo Ezio Santobuono (VE)

University of Bari, Policlinico di Bari, Bari, Italy.

Antonio Dello Russo (A)

Clinica di Cardiologia e Aritmologia, Università Politecnica delle Marche, "Ospedali Riuniti," Ancona, Italy.

Miguel Viscusi (M)

Sant' Anna e San Sebastiano Hospital, Caserta, Italy.

Carmelo La Greca (C)

Fondazione Poliambulanza, Brescia, Italy.

Claudia Baiocchi (C)

Azienda Ospedaliera Universitaria Senese, Siena, Italy.

Antonello Talarico (A)

Ospedale SS. Annunziata, Cosenza, Italy.

Raimondo Albanese (R)

Ospedale Del Mare, ASL NA1, Naples, Italy.

Giuseppe Arena (G)

Ospedale Civile Apuane, Massa, Italy.

Giovanna Giubilato (G)

"F. Spaziani" Hospital, Frosinone, Italy.

Matteo Ziacchi (M)

Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Polyclinic Sant'Orsola-Malpighi, Bologna, Italy.

Antonio Rapacciuolo (A)

olyclinic Federico II, Naples, Italy.

Monica Campari (M)

Policlinico Casilino, Rome, Italy.

Sergio Valsecchi (S)

Boston Scientific, Milan, Italy.

Giuseppe Boriani (G)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy. Electronic address: giuseppe.boriani@unimore.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH